A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease.
第一作者:
Fabio Salvatore,Macaluso
第一单位:
Inflammatory Bowel Disease Unit, A.O.O.R. 'Villa Sofia-Cervello', Palermo, Italy.
作者:
医学主题词
成年人(Adult);Crohn病(Crohn Disease);女(雌)性(Female);胃肠病用药(Gastrointestinal Agents);人类(Humans);男(雄)性(Male);倾向性评分(Propensity Score);西西里(Sicily);治疗结果(Treatment Outcome);肿瘤坏死因子α(Tumor Necrosis Factor-alpha);青年人(Young Adult)
DOI
10.1093/ecco-jcc/jjy156
PMID
30295785
发布时间
2022-04-09
- 浏览41
Journal of Crohn's & colitis
209-217页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



